Dr. Reddy's Lab gets EIR for Andhra Pradesh plant

08 May 2020 Evaluate

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA), for its API manufacturing plant at Srikakulam, Andhra Pradesh, indicating closure of the audit and the inspection classification of this facility is determined as Voluntary Action Indicated (VAI). With this, all facilities under warning letter are now determined as VAI.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1307.00 15.85 (1.23%)
05-Mar-2026 10:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.50
Dr. Reddys Lab 1307.00
Cipla 1320.40
Zydus Lifesciences 909.50
Lupin 2345.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×